Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study.
Celestino SarduPasquale PaolissoCosimo SacraCiro MauroFabio MinicucciMichele PortogheseMaria Rosaria RizzoMichelangela BarbieriFerdinando Carlo SassoNunzia D'OnofrioMaria Luisa BalestrieriPaolo CalabròGiuseppe PaolissoRaffaele MarfellaPublished in: Diabetes care (2019)
Metformin therapy may reduce the high risk of cardiovascular events in pre-DM patients by reducing coronary endothelial dysfunction.
Keyphrases
- coronary artery
- coronary artery disease
- cardiovascular events
- pulmonary artery
- ejection fraction
- end stage renal disease
- cardiovascular disease
- newly diagnosed
- percutaneous coronary intervention
- prognostic factors
- stem cells
- metabolic syndrome
- cross sectional
- type diabetes
- bone marrow
- left ventricular
- hypertrophic cardiomyopathy
- mesenchymal stem cells
- weight loss
- glycemic control